vs

Side-by-side financial comparison of Arcus Biosciences, Inc. (RCUS) and High Roller Technologies, Inc. (ROLR). Click either name above to swap in a different company.

Arcus Biosciences, Inc. is the larger business by last-quarter revenue ($11.0M vs $6.3M, roughly 1.8× High Roller Technologies, Inc.). High Roller Technologies, Inc. runs the higher net margin — 58.4% vs -963.6%, a 1022.0% gap on every dollar of revenue. On growth, High Roller Technologies, Inc. posted the faster year-over-year revenue change (-16.4% vs -52.2%). High Roller Technologies, Inc. produced more free cash flow last quarter ($-90.0K vs $-121.0M).

Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.

S&S – Sansei Technologies is an American company known for its pneumatically powered amusement rides and roller coaster designing.

RCUS vs ROLR — Head-to-Head

Bigger by revenue
RCUS
RCUS
1.8× larger
RCUS
$11.0M
$6.3M
ROLR
Growing faster (revenue YoY)
ROLR
ROLR
+35.7% gap
ROLR
-16.4%
-52.2%
RCUS
Higher net margin
ROLR
ROLR
1022.0% more per $
ROLR
58.4%
-963.6%
RCUS
More free cash flow
ROLR
ROLR
$120.9M more FCF
ROLR
$-90.0K
$-121.0M
RCUS

Income Statement — Q4 FY2025 vs Q3 FY2025

Metric
RCUS
RCUS
ROLR
ROLR
Revenue
$11.0M
$6.3M
Net Profit
$-106.0M
$3.7M
Gross Margin
Operating Margin
-1036.4%
1.3%
Net Margin
-963.6%
58.4%
Revenue YoY
-52.2%
-16.4%
Net Profit YoY
-12.8%
831.9%
EPS (diluted)
$-0.88
$0.39

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RCUS
RCUS
ROLR
ROLR
Q4 25
$11.0M
Q3 25
$6.0M
$6.3M
Q2 25
$8.0M
$6.9M
Q1 25
$8.0M
$6.8M
Q4 24
$23.0M
Q3 24
$7.0M
$7.5M
Q2 24
$11.0M
Q1 24
$10.0M
Net Profit
RCUS
RCUS
ROLR
ROLR
Q4 25
$-106.0M
Q3 25
$-135.0M
$3.7M
Q2 25
$0
$-592.0K
Q1 25
$-112.0M
$-3.3M
Q4 24
$-94.0M
Q3 24
$-92.0M
$-501.0K
Q2 24
$-93.0M
Q1 24
$-4.0M
Operating Margin
RCUS
RCUS
ROLR
ROLR
Q4 25
-1036.4%
Q3 25
-2366.7%
1.3%
Q2 25
-100.0%
-7.2%
Q1 25
-1525.0%
-47.4%
Q4 24
-447.8%
Q3 24
-1500.0%
-6.3%
Q2 24
-963.6%
Q1 24
-160.0%
Net Margin
RCUS
RCUS
ROLR
ROLR
Q4 25
-963.6%
Q3 25
-2250.0%
58.4%
Q2 25
-8.5%
Q1 25
-1400.0%
-48.4%
Q4 24
-408.7%
Q3 24
-1314.3%
-6.7%
Q2 24
-845.5%
Q1 24
-40.0%
EPS (diluted)
RCUS
RCUS
ROLR
ROLR
Q4 25
$-0.88
Q3 25
$-1.27
$0.39
Q2 25
$0.00
$-0.07
Q1 25
$-1.14
$-0.39
Q4 24
$-1.07
Q3 24
$-1.00
$-0.07
Q2 24
$-1.02
Q1 24
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RCUS
RCUS
ROLR
ROLR
Cash + ST InvestmentsLiquidity on hand
$222.0M
$2.7M
Total DebtLower is stronger
$99.0M
Stockholders' EquityBook value
$631.0M
$6.6M
Total Assets
$1.1B
$16.0M
Debt / EquityLower = less leverage
0.16×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RCUS
RCUS
ROLR
ROLR
Q4 25
$222.0M
Q3 25
$238.0M
$2.7M
Q2 25
$248.0M
$2.7M
Q1 25
$192.0M
$3.5M
Q4 24
$150.0M
Q3 24
$201.0M
$1.3M
Q2 24
$156.0M
Q1 24
$185.0M
Total Debt
RCUS
RCUS
ROLR
ROLR
Q4 25
$99.0M
Q3 25
$98.0M
Q2 25
$97.0M
Q1 25
$48.0M
Q4 24
$48.0M
Q3 24
$47.0M
Q2 24
Q1 24
Stockholders' Equity
RCUS
RCUS
ROLR
ROLR
Q4 25
$631.0M
Q3 25
$436.0M
$6.6M
Q2 25
$549.0M
$2.6M
Q1 25
$531.0M
$2.8M
Q4 24
$485.0M
Q3 24
$565.0M
$-779.0K
Q2 24
$635.0M
Q1 24
$707.0M
Total Assets
RCUS
RCUS
ROLR
ROLR
Q4 25
$1.1B
Q3 25
$974.0M
$16.0M
Q2 25
$1.1B
$12.3M
Q1 25
$1.2B
$12.8M
Q4 24
$1.1B
Q3 24
$1.3B
$12.9M
Q2 24
$1.2B
Q1 24
$1.3B
Debt / Equity
RCUS
RCUS
ROLR
ROLR
Q4 25
0.16×
Q3 25
0.22×
Q2 25
0.18×
Q1 25
0.09×
Q4 24
0.10×
Q3 24
0.08×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RCUS
RCUS
ROLR
ROLR
Operating Cash FlowLast quarter
$-120.0M
$-78.0K
Free Cash FlowOCF − Capex
$-121.0M
$-90.0K
FCF MarginFCF / Revenue
-1100.0%
-1.4%
Capex IntensityCapex / Revenue
9.1%
0.2%
Cash ConversionOCF / Net Profit
-0.02×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RCUS
RCUS
ROLR
ROLR
Q4 25
$-120.0M
Q3 25
$-97.0M
$-78.0K
Q2 25
$-133.0M
$-840.0K
Q1 25
$-132.0M
$-3.6M
Q4 24
$-100.0M
Q3 24
$26.0M
Q2 24
$-94.0M
Q1 24
$-2.0M
Free Cash Flow
RCUS
RCUS
ROLR
ROLR
Q4 25
$-121.0M
Q3 25
$-90.0K
Q2 25
$-845.0K
Q1 25
$-133.0M
$-3.6M
Q4 24
$-101.0M
Q3 24
$25.0M
Q2 24
Q1 24
$-6.0M
FCF Margin
RCUS
RCUS
ROLR
ROLR
Q4 25
-1100.0%
Q3 25
-1.4%
Q2 25
-12.2%
Q1 25
-1662.5%
-53.5%
Q4 24
-439.1%
Q3 24
357.1%
Q2 24
Q1 24
-60.0%
Capex Intensity
RCUS
RCUS
ROLR
ROLR
Q4 25
9.1%
Q3 25
0.0%
0.2%
Q2 25
0.0%
0.1%
Q1 25
12.5%
0.2%
Q4 24
4.3%
Q3 24
14.3%
Q2 24
0.0%
Q1 24
40.0%
Cash Conversion
RCUS
RCUS
ROLR
ROLR
Q4 25
Q3 25
-0.02×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

RCUS
RCUS

Other$5.0M45%
Other Collaboration Revenue$4.0M36%
Access Rights And Option Continuation Periods$2.0M18%

ROLR
ROLR

Net Gaming Revenue$4.9M77%
Net Revenue Noncore Services$1.4M23%

Related Comparisons